Skip to main content
SpringerLink
Log in

Coombs’ test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs’ test negative after azacitidine administration

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

The data of this case report are available from the corresponding author, Shinya Yamada, upon reasonable request.

Code availability

Not applicable.

References

  1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405. https://doi.org/10.1182/blood-2016-03-643544

    Article  CAS  PubMed  Google Scholar 

  2. Grigano E, Jachiet V, Fenaux P, Ades L, Fain O, Mekinian A (2018) Autoimmune manifestations associated with myelodysplastic syndromes. Ann Hematol 97(11):2015–2023. https://doi.org/10.1007/s00277-018-3472-9

    Article  CAS  Google Scholar 

  3. Jäger U, Barcellini W, Broome CM (2020) Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev 41:100648. https://doi.org/10.1016/j.blre.2019.100648

    Article  CAS  PubMed  Google Scholar 

  4. Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H (2006) Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 108(2):419–425. https://doi.org/10.1182/blood-2005-10-4149

    Article  CAS  PubMed  Google Scholar 

  5. Pilorge S, Doleris LM, Dreyfus F, Park S (2011) The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases. Br J Haematol 153(5):664–665. https://doi.org/10.1111/j.1365-2141.2010.08557.x

    Article  PubMed  Google Scholar 

  6. Tanaka H, Shimizu N, Tougasaki E, Kawajiri C, Hashimoto S, Takeda Y, Sakai S, Takeuchi M, Ohwada C, Sakaida E, Takagi T, Nakaseko C (2013) Successful treatment by azacitidine therapy of intestinal Behçet’s disease associated with myelodysplastic syndrome. Int J Hematol 97(4):520–524. https://doi.org/10.1007/s12185-013-1316-x

    Article  PubMed  Google Scholar 

  7. Lin JT, Wang WS, Yen CC, Chiou TJ, Liu JH, Hsiao LT, Yang MH, Chao TC, Tai CJ, Chen PM (2002) Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil. Ann Hematol 81(12):723–726. https://doi.org/10.1007/s00277-002-0539-3

    Article  PubMed  Google Scholar 

  8. Oren H, Uçar C, Gülen H, Duman M, Irken G (2001) Autoimmune hemolytic anemia occurring with myelodysplastic syndrome: report of a pediatric case and review of literature. Ann Hematol 80(9):540–542. https://doi.org/10.1007/s002770100332

    Article  CAS  PubMed  Google Scholar 

  9. Kaur J, Tuler S, Dasanu CA (2021) Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: responding to 5-azacitidine therapy. J Oncol Pharm Pract. https://doi.org/10.1177/1078155220987616

    Article  PubMed  Google Scholar 

  10. Okada M, Okamoto T, Takemoto Y, Kanamaru A, Kakishita E (2000) Function and X chromosome inactivation analysis of B lymphocytes in myelodysplastic syndromes with immunological abnormalities. Acta Haematol 102(3):124–130. https://doi.org/10.1159/000040985

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Toyama Prefectural Central Hospital, 2-2-78 Nishinagae, Toyama City, Toyama Prefecture, 930-8550, Japan

    Shinya Yamada, Sayaka Kajikawa, Noriharu Nakagawa, Yukio Kondo & Hirokazu Okumura

Authors
  1. Shinya Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sayaka Kajikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noriharu Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yukio Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirokazu Okumura
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Shinya Yamada and Sayaka Kajikawa were attending physicians. Hirokazu Okumura was a medical advisor. Noriharu Nakagawa and Yukio Kondo made suggestions about writing this letter.

Corresponding author

Correspondence to Shinya Yamada.

Ethics declarations

Ethics approval

Informed consent was obtained from the patient.

Consent to participate

Informed consent was obtained from the patient.

Consent for publication

Informed consent was obtained from the patient.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, S., Kajikawa, S., Nakagawa, N. et al. Coombs’ test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs’ test negative after azacitidine administration. Ann Hematol 101, 915–917 (2022). https://doi.org/10.1007/s00277-021-04652-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04652-3

Search

Navigation